These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16627342)

  • 21. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
    Dullaers M; Thielemans K
    J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of MUC1 and distribution of tumor-infiltrating dentritic cells in human bladder transitional cell carcinoma].
    Xiang ST; Zhou SW; Guan W; Liu JH; Ye ZQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1114-8. PubMed ID: 16174576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination.
    Freire T; Lo-Man R; Piller F; Piller V; Leclerc C; Bay S
    Glycobiology; 2006 May; 16(5):390-401. PubMed ID: 16449349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro dendritic cell infection by pseudotyped adenoviral vectors does not correlate with their in vivo immunogenicity.
    Hsu C; Boysen M; Gritton LD; Frosst PD; Nemerow GR; Von Seggern DJ
    Virology; 2005 Feb; 332(1):1-7. PubMed ID: 15661134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune characterization of clinical grade-dendritic cells generated from cancer patients and genetically modified by an ALVAC vector carrying MAGE minigenes.
    Trakatelli M; Toungouz M; Lambermont M; Heenen M; Velu T; Bruyns C
    Cancer Gene Ther; 2005 Jun; 12(6):552-9. PubMed ID: 15665821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cell generated from CD34+ hematopoietic progenitors can be transfected with adenovirus containing gene of HBsAg and induce antigen-specific cytotoxic T cell responses.
    Yang JY; Cao DY; Liu WC; Zhang HM; Teng ZH; Ren J
    Cell Immunol; 2006 Mar; 240(1):14-21. PubMed ID: 16875681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials.
    Mossoba ME; Medin JA
    Expert Rev Vaccines; 2006 Oct; 5(5):717-32. PubMed ID: 17181444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination.
    Chan T; Sami A; El-Gayed A; Guo X; Xiang J
    Gene Ther; 2006 Oct; 13(19):1391-402. PubMed ID: 16724093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene.
    Wei X; Xu H; Kufe D
    Cancer Res; 2007 Feb; 67(4):1853-8. PubMed ID: 17308127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
    Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
    Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surface Mucin-1 does not play a role in dendritic cell migration.
    Cloosen S; Caberg JH; Huls MB; Vanderlocht J; Senden-Gijsbers BL; Roncarati P; Hubert P; Delvenne P; Germeraad WT; Bos GM
    Mol Immunol; 2009 Feb; 46(4):738-42. PubMed ID: 18952292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single-component CD40-targeted adenovirus vector displays highly efficient transduction and activation of dendritic cells in a human skin substrate system.
    Korokhov N; Noureddini SC; Curiel DT; Santegoets SJ; Scheper RJ; de Gruijl TD
    Mol Pharm; 2005; 2(3):218-23. PubMed ID: 15934782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presentation of tumor antigens.
    Hart DN; Schultze JL; Stewart AK
    Semin Hematol; 1999 Jan; 36(1 Suppl 3):21-5. PubMed ID: 9989485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human tumor antigen MUC1 expressed in insect cells: structure and immunogenicity.
    Soares M; Hanisch FG; Finn OJ; Ciborowski P
    Protein Expr Purif; 2001 Jun; 22(1):92-100. PubMed ID: 11388805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
    Sørensen AL; Reis CA; Tarp MA; Mandel U; Ramachandran K; Sankaranarayanan V; Schwientek T; Graham R; Taylor-Papadimitriou J; Hollingsworth MA; Burchell J; Clausen H
    Glycobiology; 2006 Feb; 16(2):96-107. PubMed ID: 16207894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors involved in the maturation of murine dendritic cells transduced with adenoviral vector variants.
    Kanagawa N; Koretomo R; Murakami S; Sakurai F; Mizuguchi H; Nakagawa S; Fujita T; Yamamoto A; Okada N
    Virology; 2008 May; 374(2):411-20. PubMed ID: 18272197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapy.
    Tosch C; Geist M; Ledoux C; Ziller-Remi C; Paul S; Erbs P; Corvaia N; Von Hoegen P; Balloul JM; Haegel H
    Cancer Gene Ther; 2009 Apr; 16(4):310-9. PubMed ID: 18949016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice].
    Tan G; Wang ZY; Yin S
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):943-6. PubMed ID: 16759530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies.
    Van Elssen CH; Clausen H; Germeraad WT; Bennet EP; Menheere PP; Bos GM; Vanderlocht J
    J Immunol Methods; 2011 Feb; 365(1-2):87-94. PubMed ID: 21194532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.